// App-Quantinova.ai

1819 : Stromal Sulfatase‐2 ‐ a critical regulator of hepatocellular carcinoma growth and migration

Researchers

Presenter

  • Marco Y. Zaki

Principal Investigators

  • Lee Borthwick

  • Sari Alhasan

  • Julie Worrell

  • Ruchi Shukla

  • Dina Tiniakos

  • Helen Reeves

  • Fiona Oakley

Medical Centers

  • Northern Institute for Cancer Research (NICR), Institute of Cellular Medicine (ICM), Newcastle University, Newcastle upon Tyne, United Kingdom

  • Northern institute for cancer research (NICR), Newcatle University‐ Newcastle Upon Tyne‐ UK, Newcastle upon Tyne, United Kingdom

  • NFRG‐ Institute of Cellular Medicine (ICM), Newcatle University‐ Newcastle Upon Tyne‐ UK, Newcastle upon Tyne, United Kingdom

  • Biochemistry Department, Minia University, Minia, Egypt

  • Hepatopancreatobiliary multidisciplinary team & Liver Unit, Freeman Hospital, Newcastle‐upon‐Tyne NHS Foundation Trust, Newcastle upon Tyne, United Kingdom

  • NFRG‐ Institute of Cellular Medicine (ICM), Newcatle University‐ Newcastle Upon Tyne‐ UK, Newcastle upon Tyne, United Kingdom

Locations

  • United Kingdom

  • Egypt

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Liver cancer

  • Solid malignancies

Biomarkers

  • Sulfatase-2

Drug/Treatment

  • Sorafenib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved